SEC Filing Analysis: Acrivon Therapeutics, Inc. (ACRV)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Operating Officer, Eric Devroe, made a small open-market purchase of common stock valued at approximately $17,218.
• Market Impact: The transaction is too small to have a material impact on the stock.

Company Information

Field	Value
Company	Acrivon Therapeutics, Inc.
Ticker Symbol	ACRV
CIK	0001781174
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Devroe Eric
CIK	0001950573
Title/Position	Chief Operating Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-01-13
Transaction Code	P (Open Market Purchase)
Security Type	Common Stock
Shares Involved	10,000
Price Per Share	$1.7218
Total Value	$17,218
Shares Owned After	75,308
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$17,218
% of Market Cap	0.025%
Shares Transacted	10,000
% of Shares Outstanding	Not Available
Post-Transaction Ownership	75,308 shares (Ownership % Not Available)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Acrivon Therapeutics has a market capitalization of approximately $70 million. The $17,218 transaction represents a negligible fraction (0.025%) of this value, indicating it is not a financially significant event for the company.
• Ownership Concentration: Without data on shares outstanding, the insider's percentage ownership cannot be calculated. However, the purchase increases the COO's direct holdings by approximately 15%.
• Transaction Significance: The purchase is considered to have low significance due to its very small value relative to the company's market capitalization. While insider buys are generally viewed positively, the size of this transaction limits its signaling power.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction value is too small to be considered a strong bullish signal or to materially affect supply and demand for the stock.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction is unlikely to influence trading volume.
• Sentiment Indicator: Neutral. The purchase is a minor positive data point but is not substantial enough to shift overall market sentiment.

Additional Context

Transaction Notes

• The reported price of $1.7218 is a weighted average. The shares were purchased in multiple trades at prices ranging from $1.719 to $1.7268.